Investors are piling into bets against Takata as the U.S. pushes for nationwide recalls to replace its faulty airbags and members of Congress prepare to renew their scrutiny of defects linked to five deaths.
Investors are piling into bets against Takata as the U.S. pushes for nationwide recalls to replace its faulty airbags and members of Congress prepare to renew their scrutiny of defects linked to five deaths.